BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 30632682)

  • 21. Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort Study.
    Stiebel-Kalish H; Lotan I; Brody J; Chodick G; Bialer O; Marignier R; Bach M; Hellmann MA
    PLoS One; 2017; 12(1):e0170847. PubMed ID: 28125740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical value of complement proteins in differentiating AQP4-IgG-positive from MOG-IgG-positive neuromyelitis optica spectrum disorders.
    Qin C; Chen B; Tao R; Chen M; Ma X; Shang K; Wu LJ; Wang W; Bu BT; Tian DS
    Mult Scler Relat Disord; 2019 Oct; 35():1-4. PubMed ID: 31276911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical characteristics of myelin oligodendrocyte glycoprotein seropositive optic neuritis: a cohort study in Shanghai, China.
    Zhao G; Chen Q; Huang Y; Li Z; Sun X; Lu P; Yan S; Wang M; Tian G
    J Neurol; 2018 Jan; 265(1):33-40. PubMed ID: 29101456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical characteristics of myelin oligodendrocyte glycoprotein antibody-positive optic neuritis].
    Song HL; Wei SH
    Zhonghua Yan Ke Za Zhi; 2019 Mar; 55(3):174-179. PubMed ID: 30841683
    [No Abstract]   [Full Text] [Related]  

  • 25. Epidemiologic and Clinical Characteristics of Optic Neuritis in Japan.
    Ishikawa H; Kezuka T; Shikishima K; Yamagami A; Hiraoka M; Chuman H; Nakamura M; Hoshi K; Goseki T; Mashimo K; Mimura O; Yoshitomi T; Tanaka K;
    Ophthalmology; 2019 Oct; 126(10):1385-1398. PubMed ID: 31196727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies in immune-mediated optic neuritis at long-term follow-up.
    Petzold A; Woodhall M; Khaleeli Z; Tobin WO; Pittock SJ; Weinshenker BG; Vincent A; Waters P; Plant GT
    J Neurol Neurosurg Psychiatry; 2019 Sep; 90(9):1021-1026. PubMed ID: 31118222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aquaporin 4 antibody [NMO Ab] status in patients with severe optic neuritis in India.
    Ambika S; Balasubramanian M; Theresa L; Veeraputhiran A; Arjundas D
    Int Ophthalmol; 2015 Dec; 35(6):801-6. PubMed ID: 25682013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anti-Myelin Oligodendrocyte Glycoprotein Antibodies in Paediatric Patients with Optic Neuritis].
    Tegetmeyer H; Merkenschlager A
    Klin Monbl Augenheilkd; 2017 Oct; 234(10):1243-1249. PubMed ID: 29025172
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical and MRI phenotype of children with MOG antibodies.
    Fernandez-Carbonell C; Vargas-Lowy D; Musallam A; Healy B; McLaughlin K; Wucherpfennig KW; Chitnis T
    Mult Scler; 2016 Feb; 22(2):174-84. PubMed ID: 26041801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis.
    Nakajima H; Motomura M; Tanaka K; Fujikawa A; Nakata R; Maeda Y; Shima T; Mukaino A; Yoshimura S; Miyazaki T; Shiraishi H; Kawakami A; Tsujino A
    BMJ Open; 2015 Apr; 5(4):e007766. PubMed ID: 25838512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody.
    Dubey D; Pittock SJ; Krecke KN; Morris PP; Sechi E; Zalewski NL; Weinshenker BG; Shosha E; Lucchinetti CF; Fryer JP; Lopez-Chiriboga AS; Chen JC; Jitprapaikulsan J; McKeon A; Gadoth A; Keegan BM; Tillema JM; Naddaf E; Patterson MC; Messacar K; Tyler KL; Flanagan EP
    JAMA Neurol; 2019 Mar; 76(3):301-309. PubMed ID: 30575890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.
    Chen JJ; Flanagan EP; Jitprapaikulsan J; López-Chiriboga ASS; Fryer JP; Leavitt JA; Weinshenker BG; McKeon A; Tillema JM; Lennon VA; Tobin WO; Keegan BM; Lucchinetti CF; Kantarci OH; McClelland CM; Lee MS; Bennett JL; Pelak VS; Chen Y; VanStavern G; Adesina OO; Eggenberger ER; Acierno MD; Wingerchuk DM; Brazis PW; Sagen J; Pittock SJ
    Am J Ophthalmol; 2018 Nov; 195():8-15. PubMed ID: 30055153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Etiologies of acute demyelinating optic neuritis: an observational study of 110 patients.
    Deschamps R; Lecler A; Lamirel C; Aboab J; Gueguen A; Bensa C; Vignal C; Gout O
    Eur J Neurol; 2017 Jun; 24(6):875-879. PubMed ID: 28477397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevalence and prognostic value of myelin oligodendrocyte glycoprotein antibody in adult optic neuritis.
    Liu H; Zhou H; Wang J; Sun M; Teng D; Song H; Xu Q; Wei S
    J Neurol Sci; 2019 Jan; 396():225-231. PubMed ID: 30522039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis?
    Stiebel-Kalish H; Hellmann MA; Mimouni M; Paul F; Bialer O; Bach M; Lotan I
    Neurol Neuroimmunol Neuroinflamm; 2019 Jul; 6(4):e572. PubMed ID: 31355308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical profile, imaging features and short term visual outcomes of Indian optic neuritis patients with and without seromarkers for myelin oligodendrocyte glycoprotein and neuromyelitis optica.
    Ambika S; Durgapriyadarshini S; Padmalakshmi K; Noronha V; Arjundas D
    Indian J Ophthalmol; 2022 Jan; 70(1):194-200. PubMed ID: 34937238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optic neuritis in the era of biomarkers.
    Chen JJ; Pittock SJ; Flanagan EP; Lennon VA; Bhatti MT
    Surv Ophthalmol; 2020; 65(1):12-17. PubMed ID: 31425702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.
    Jarius S; Kleiter I; Ruprecht K; Asgari N; Pitarokoili K; Borisow N; Hümmert MW; Trebst C; Pache F; Winkelmann A; Beume LA; Ringelstein M; Stich O; Aktas O; Korporal-Kuhnke M; Schwarz A; Lukas C; Haas J; Fechner K; Buttmann M; Bellmann-Strobl J; Zimmermann H; Brandt AU; Franciotta D; Schanda K; Paul F; Reindl M; Wildemann B;
    J Neuroinflammation; 2016 Nov; 13(1):281. PubMed ID: 27802825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics and outcomes of myelin oligodendrocyte glycoprotein antibody-seropositive optic neuritis in varying age groups: A cohort study in China.
    Song H; Zhou H; Yang M; Xu Q; Sun M; Wei S
    J Neurol Sci; 2019 May; 400():83-89. PubMed ID: 30904690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies to myelin oligodendrocyte glycoprotein in chronic relapsing inflammatory optic neuropathy.
    Liu H; Zhou H; Wang J; Xu Q; Wei S
    Br J Ophthalmol; 2019 Oct; 103(10):1423-1428. PubMed ID: 30514710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.